Rational manipulation of mRNA folding free energy allows rheostat control of pneumolysin production by Streptococcus pneumoniae

PloS One
Fábio E AmaralAdam J Ratner

Abstract

The contribution of specific factors to bacterial virulence is generally investigated through creation of genetic "knockouts" that are then compared to wild-type strains or complemented mutants. This paradigm is useful to understand the effect of presence vs. absence of a specific gene product but cannot account for concentration-dependent effects, such as may occur with some bacterial toxins. In order to assess threshold and dose-response effects of virulence factors, robust systems for tunable expression are required. Recent evidence suggests that the folding free energy (ΔG) of the 5' end of mRNA transcripts can have a significant effect on translation efficiency and overall protein abundance. Here we demonstrate that rational alteration of 5' mRNA folding free energy by introduction of synonymous mutations allows for predictable changes in pneumolysin (PLY) expression by Streptococcus pneumoniae without the need for chemical inducers or heterologous promoters. We created a panel of isogenic S. pneumoniae strains, differing only in synonymous (silent) mutations at the 5' end of the PLY mRNA that are predicted to alter ΔG. Such manipulation allows rheostat-like control of PLY production and alters the cytotoxicity of whole S....Continue Reading

References

Jul 1, 1988·Reviews of Infectious Diseases·D E BrilesL S McDaniel
May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·P E Shockett, D G Schatz
Jul 8, 1999·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·B K DeG M Carlone
Oct 27, 2001·Applied and Environmental Microbiology·C K SungD A Morrison
Apr 22, 1960·Biochimica Et Biophysica Acta·S LACKS, R D HOTCHKISS
Jun 28, 2005·Nucleic Acids Research·Nicholas R Markham, Michael Zuker
Nov 15, 2006·Molecular Biology and Evolution·Nina Stoletzki, Adam Eyre-Walker
Jun 28, 2008·Science·J Robert ColemanSteffen Mueller
Sep 18, 2008·Biology Direct·Pere PuigbòSantiago Garcia-Vallve
Nov 6, 2008·Annual Review of Genetics·Ruth Hershberg, Dmitri A Petrov
Apr 11, 2009·Science·Grzegorz KudlaJoshua B Plotkin
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Tamir TullerEytan Ruppin
Dec 21, 2010·Journal of Bacteriology·Ryan RampersaudAdam J Ratner
Feb 24, 2011·The Journal of Infectious Diseases·J Robert ColemanLiise-Anne Pirofski
May 24, 2013·Microbiology and Molecular Biology Reviews : MMBR·Ferdinand C O LosAdam J Ratner
Jun 26, 2013·Cell·Premal ShahJoshua B Plotkin
Aug 8, 2013·Nucleic Acids Research·Masa RollerKristian Vlahovicek
Sep 28, 2013·Science·Daniel B GoodmanSriram Kosuri

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
ELISA
reverse-transcription PCR

Software Mentioned

Prism
ImageJ

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.